Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ribi

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Journal of Biological Response Modifiers|January 1, 1984
Beneficial modification of the endotoxin moleculeE Ribi
The Journal of Infectious Diseases|May 1, 1971
Currents in tuberculosis researchE Ribi
Preparative Biochemistry|January 1, 1980
A shortened synthesis of adjuvant dipeptide (MDP)S M Schwartzman, E Ribi
The Journal of Biological Chemistry|October 10, 1982
Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimuriumN Qureshi, K Takayama, E Ribi
Praxis Und Klinik Der Pneumologie|April 1, 1979
[Immunotherapy with BCG and mycobacterial fractions and its use in bronchogenic carcinoma (author's transl)]W Brehmer, H Huckauf, E Ribi
Methods of Biochemical Analysis|January 1, 1974
Microparticulate gel chromatography accelerated by centrifugal force and pressureE Ribi, R Parker, K Milner
Japanese Journal of Microbiology|July 1, 1974
Preparation of an adjuvant-active, tuberculin-free peptidoglycolipid from human tubercle bacilliI Azuma, Y Yamamura, E Ribi
Cellular Immunology|March 1, 1975
Biologically active components from mycobacterial cell walls. V. Granuloma formation in mouse lungs and guinea pig skinT J Meyer, E Ribi, I Azuma
Cancer Research|July 1, 1981
Isolation of a nontoxic lipid A fraction containing tumor regression activityK Takayama, E Ribi, J L Cantrell
Infection and Immunity|June 1, 1970
Macrophage Migration Inhibition Studies with Cells from Mice Vaccinated with Cell Walls of Mycobacterium bovis BCG: Relationship Between Inhibitory Activity of Lung Cells and Resistance to Airborne Challenge with Mycobacterium tuberculosis H37RvK Yamamoto, R L Anacker, E Ribi
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Journal of Biological Response Modifiers|January 1, 1984
Beneficial modification of the endotoxin moleculeE Ribi
The Journal of Infectious Diseases|May 1, 1971
Currents in tuberculosis researchE Ribi
Preparative Biochemistry|January 1, 1980
A shortened synthesis of adjuvant dipeptide (MDP)S M Schwartzman, E Ribi
The Journal of Biological Chemistry|October 10, 1982
Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimuriumN Qureshi, K Takayama, E Ribi
Praxis Und Klinik Der Pneumologie|April 1, 1979
[Immunotherapy with BCG and mycobacterial fractions and its use in bronchogenic carcinoma (author's transl)]W Brehmer, H Huckauf, E Ribi
Methods of Biochemical Analysis|January 1, 1974
Microparticulate gel chromatography accelerated by centrifugal force and pressureE Ribi, R Parker, K Milner
Japanese Journal of Microbiology|July 1, 1974
Preparation of an adjuvant-active, tuberculin-free peptidoglycolipid from human tubercle bacilliI Azuma, Y Yamamura, E Ribi
Cellular Immunology|March 1, 1975
Biologically active components from mycobacterial cell walls. V. Granuloma formation in mouse lungs and guinea pig skinT J Meyer, E Ribi, I Azuma
Cancer Research|July 1, 1981
Isolation of a nontoxic lipid A fraction containing tumor regression activityK Takayama, E Ribi, J L Cantrell
Infection and Immunity|June 1, 1970
Macrophage Migration Inhibition Studies with Cells from Mice Vaccinated with Cell Walls of Mycobacterium bovis BCG: Relationship Between Inhibitory Activity of Lung Cells and Resistance to Airborne Challenge with Mycobacterium tuberculosis H37RvK Yamamoto, R L Anacker, E Ribi
Pageof 8